Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 6, Pages -
Publisher
American Society for Microbiology
Online
2020-03-16
DOI
10.1128/aac.02111-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments
- (2020) P. Wistrand-Yuen et al. CLINICAL MICROBIOLOGY AND INFECTION
- The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification
- (2019) Hervé Nicoloff et al. Nature Microbiology
- Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals
- (2019) Mariana Castanheira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multi-center evaluation of colistin broth disk elution and colistin agar test: a report from the Clinical and Laboratory Standards Institute
- (2019) Romney M. Humphries et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Constitutive Activation of MexT by Amino Acid Substitutions Results in MexEF-OprN Overproduction in Clinical Isolates of Pseudomonas aeruginosa
- (2018) Paulo Juarez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Automated time-lapse microscopy a novel method for screening of antibiotic combination effects against multidrug-resistant Gram-negative bacteria
- (2018) W. Ungphakorn et al. CLINICAL MICROBIOLOGY AND INFECTION
- Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa
- (2018) Manju Suresh et al. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
- The Versatile Mutational Resistome of Pseudomonas aeruginosa
- (2018) Carla López-Causapé et al. Frontiers in Microbiology
- Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin
- (2017) Agata Turlej-Rogacka et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Evaluation of automated time-lapse microscopy for assessment of in vitro activity of antibiotics
- (2017) Wanchana Ungphakorn et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Amikacin: Uses, Resistance, and Prospects for Inhibition
- (2017) Maria Ramirez et al. MOLECULES
- Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene
- (2017) Ryota Ito et al. mBio
- Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
- (2016) Alexandre P. Zavascki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa
- (2016) Yuka Yamagishi et al. CHEMOTHERAPY
- Synergistic combinations of polymyxins
- (2016) Justin R. Lenhard et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii
- (2016) Gauri G. Rao et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing ofPseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance
- (2016) Clare C. Walsh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin B in Combination with Antimicrobials LackingIn VitroActivity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections
- (2015) Maria Helena Rigatto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of Minocycline and Polymyxin B Combination against Acinetobacter baumannii
- (2015) Dana R. Bowers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae byIn VitroTime-Kill Experiments
- (2014) T. Tängdén et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroEvaluation of the Antimicrobial Activity of Meropenem in Combination with Polymyxin B and Gatifloxacin AgainstPseudomonas aeruginosaandAcinetobacter baumannii
- (2014) K.C. Guelfi et al. JOURNAL OF CHEMOTHERAPY
- Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections
- (2014) Nihal Martis et al. JOURNAL OF INFECTION
- Multiple Mutations Lead to MexXY-OprM-Dependent Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa
- (2013) Sophie Guénard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of acquired antimicrobial resistance genes
- (2012) E. Zankari et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of polymyxins in combination with β-lactams against clinical strains of Pseudomonas aeruginosa
- (2011) Cecília Saori Mitsugui et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Aminoglycoside modifying enzymes
- (2010) Maria S. Ramirez et al. DRUG RESISTANCE UPDATES
- Diversity, Epidemiology, and Genetics of Class D -Lactamases
- (2009) L. Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure−Activity Relationships of Polymyxin Antibiotics
- (2009) Tony Velkov et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More